Karin Briner

Last updated

Karin Briner is a medicinal chemist and pharmaceutical executive currently employed as Senior Vice President, Head of Drug Discovery at Genentech.

Contents

Karin Briner, Ph.D.
NationalitySwiss
Scientific career
Doctoral advisor Andrea Vasella
Other academic advisorsWilliam Roush

Education

Briner received her B.S. and Ph.D. degrees working at the University of Zurich with Professor Andrea Vasella. [1] She pursued postdoctoral studies at Indiana University with Prof. William Roush, [2] developing new methods to stereoselectively synthesize natural product glycosides. [3]

Career

After completing postdoctoral studies, Briner was hired at Eli Lilly & Company as a Senior Chemist in Infectious Diseases. Her work eventually evolved into central nervous system disorders such as depression, evidenced by multiple selective compounds against various serotonin receptors. She became the Managing Director of the Lilly Research Centre, UK, from 2007–2010. Briner was hired by the Novartis Institutes for Biomedical Research as the Global Head of Chemistry in 2011. Since that time, her team has been involved in the development of multiple new drug launches, for example nilotinib, [4] ceritinib, panobinostat, and Entresto. Briner left Novartis in late 2022, and is currently Senior Vice President, Head of Drug Discovery at Genentech.

Volunteer service

Briner was a founding member of the Innovative Medicines Initiative (IMI), and remains active in professional societies such as the European Federation for Medicinal Chemistry [5] and the American Chemical Society. She has delivered plenary talks at multiple scientific meetings. [6] She was active in a mentoring capacity to incoming postdoctoral and Summer scholars at Novartis. [7]

Briner maintains an entry for the chemical production and purification of elemental lithium at EROS. [8]

Related Research Articles

<span class="mw-page-title-main">Chemist</span> Scientist trained in the study of chemistry

A chemist is a graduated scientist trained in the study of chemistry, or an officially enrolled student in the relevant field. Chemists study the composition of matter and its properties. Chemists carefully describe the properties they study in terms of quantities, with detail on the level of molecules and their component atoms. Chemists carefully measure substance proportions, chemical reaction rates, and other chemical properties. In Commonwealth English, pharmacists are often called chemists.

<span class="mw-page-title-main">Medicinal chemistry</span> Scientific branch of chemistry

Medicinal or pharmaceutical chemistry is a scientific discipline at the intersection of chemistry and pharmacy involved with designing and developing pharmaceutical drugs. Medicinal chemistry involves the identification, synthesis and development of new chemical entities suitable for therapeutic use. It also includes the study of existing drugs, their biological properties, and their quantitative structure-activity relationships (QSAR).

<span class="mw-page-title-main">Raymond Lemieux</span> Canadian organic chemist (1920–2000)

Raymond Urgel Lemieux, CC, AOE, FRS was a Canadian organic chemist, who pioneered many discoveries in the field of chemistry, his first and most famous being the synthesis of sucrose. His contributions include the discovery of the anomeric effect and the development of general methodologies for the synthesis of saccharides still employed in the area of carbohydrate chemistry. He was a fellow of the Royal Society of Canada and the Royal Society (England), and a recipient of the prestigious Albert Einstein World Award of Science and Wolf Prize in Chemistry.

Nitya Anand is a medicinal chemist who was the director of Central Drug Research Institute in Lucknow from 1974 to 1984. In 2005, Indian Pharmacopoeia Commission (IPC) appointed him chairman of its scientific committee. In 2012, he was awarded the Padma Shri by the Indian government.

Bruce Eliot Maryanoff FRSC is an American medicinal and organic chemist.

Bruce D. Roth is an American organic and medicinal chemist who trained at Saint Joseph's College, Iowa State University and the University of Rochester, and, at the age of 32, discovered atorvastatin, the statin-class drug sold as Lipitor that would become the largest-selling drug in pharmaceutical history. His honours include being named a 2008 Hero of Chemistry by the American Chemical Society, and being chosen as the Perkin Medal awardee, the highest honour given in the U.S. chemical industry, by the Society of Chemical Industry, American section in 2013.

Charon Robin Ganellin FRS is a British medicinal chemist, and Emeritus Smith Kline and French Professor of Medicinal Chemistry, at University College London.

<span class="mw-page-title-main">Cynthia A. Maryanoff</span> American chemist

Cynthia "Cyndie" Anne Maryanoff is an American organic and materials chemist. Among other awards, she received the 2015 Perkin Medal for outstanding work in applied chemistry in the U.S.A.

Derek Lowe is a medicinal chemist working on preclinical drug discovery in the pharmaceutical industry. Lowe has published a blog about this field, "In the Pipeline", since 2002 and is a columnist for the Royal Society of Chemistry's Chemistry World.

<span class="mw-page-title-main">William R. Roush</span> American organic chemist

William R. Roush is an American organic chemist. He studied chemistry at the University of California Los Angeles and Harvard University. Following a year postdoctoral appointment at Harvard, he joined that faculty at the Massachusetts Institute of Technology. In 1987, Dr. Roush moved to Indiana University and was promoted to Professor in 1989 and Distinguished Professor in 1995. Two years later, he moved to the University of Michigan in Ann Arbor and served as the Warner Lambert/Parke Davis Professor of Chemistry. He served as chair of the University of Michigan's Department of Chemistry from 2002-2004. In 2004 Professor Roush relocated with his group to the Jupiter, Florida, campus of the Scripps Research Institute (TSRI) where he is currently an emeritus professor.

<span class="mw-page-title-main">Edmund Kornfeld</span>

Edmund Carl Kornfeld was an American organic chemist who devoted his life to the research of new drugs. His leading discovery, with the help of a team, was an antibiotic that was later named vancomycin.

<span class="mw-page-title-main">Women in chemistry</span> Female contributors to the field of chemistry

This is a list of women chemists. It should include those who have been important to the development or practice of chemistry. Their research or application has made significant contributions in the area of basic or applied chemistry.

Michael J. Sofia is a chemist whose main research focus is hepatitis C virus and hepatitis B virus drug discovery. He was a co-recipient of the Lasker-DeBakey Clinical Medical Research Award for his work on hepatitis C in 2016 and of the Gertrude B. Elion Memorial Award from the International Society for Antiviral Research in 2017.

Lisa Ann Marcaurelle is an American chemist and a senior executive in multiple biotechnology companies.

Wendy B. Young is a medicinal chemist and pharmaceutical executive currently employed at Genentech.

<span class="mw-page-title-main">Vy Maria Dong</span> American chemist

Vy Maria Dong is a Vietnamese-American Chancellor's Professor of Chemistry at the University of California, Irvine (UCI). Dong works on enantioselective catalysis and natural product synthesis. She received the Royal Society of Chemistry's Merck, Sharp & Dohme Award in 2020, the American Chemical Society's Elias James Corey Award in 2019, and the UCI's Distinguished Alumni Award in 2018.

Johanna Maria "Hanneke" Jansen is a computational chemist working at Novartis on multiple drug targets. She previously worked at Astra and at Chiron Corporation.

Jin-Quan Yu is a Chinese-born American chemist. He is the Frank and Bertha Hupp Professor of Chemistry at Scripps Research, where he also holds the Bristol Myers Squibb Endowed Chair in Chemistry. He is a 2016 recipient of the MacArthur Fellowship, and is a member of the American Academy of Arts and Sciences, American Association for the Advancement of Science, and the Royal Society of Chemistry. Yu is a leader in the development of C–H bond activation reactions in organic chemistry, and has reported many C–H activation reactions that could be applicable towards the synthesis of drug molecules and other biologically active compounds. He also co-founded Vividion Therapeutics in 2016 with fellow Scripps chemists Benjamin Cravatt and Phil Baran, and is a member of the scientific advisory board of Chemveda Life Sciences.

Alfred Burger was a prominent chemist and a pioneer in medical chemistry. Burger was born in Vienna, the capitol of the Austro-Hungarian Empire, on 6 September 1905. He was the son of S. L. Burger and Clariss Burger.

<span class="mw-page-title-main">Amy Hauck Newman</span> American medicinal chemist

Amy Hauck Newman is an American medicinal chemist who is the scientific director of the intramural research program at the National Institute on Drug Abuse. She researches the design, synthesis, and evaluation of central nervous system (CNS) active agents as potential treatment medications for substance use disorders, with an emphasis on selective ligands for the dopaminergic system.

References

  1. "Karin Briner, Ph.D. | Novartis". Novartis. Retrieved 2018-10-22.
  2. "Roush Research Personnel". www.scripps.edu. Retrieved 2018-10-22.
  3. Roush, William R.; Briner, Karin; Kesler, Brenda S.; Murphy, Megan; Gustin, Darin J. (January 1996). "Studies on the Synthesis of Aureolic Acid Antibiotics: Acyloin Glycosidation Studies". The Journal of Organic Chemistry. 61 (18): 6098–6099. doi:10.1021/jo960932e. ISSN   0022-3263. PMID   11667440.
  4. Ainsworth, Susan J. "Merck & Co., Novartis, And Arkema Chemists Honored For Discoveries | Chemical & Engineering News". cen.acs.org. Retrieved 2018-10-22.
  5. "EFMC Scientific Advisory Board". www.efmc.info. Retrieved 2018-10-22.
  6. Briner, Karin (2014). "Evolution of Medicinal Chemistry: Outlook and Opportunities" . Retrieved 22 October 2018.
  7. "Karin Briner, Ph.D. | Novartis". Novartis. Retrieved 2018-10-22.
  8. Briner, Karin; Mathes, Brian M.; Ramón, Diego J.; Yus, Miguel (2014-10-20), "Lithium", Encyclopedia of Reagents for Organic Synthesis, John Wiley & Sons, Ltd, pp. 1–8, doi:10.1002/047084289x.rl034.pub3, ISBN   9780470842898